HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Celeste Decker Selected Research

human GALNS protein

1/2018Impact of long-term elosulfase alfa on activities of daily living in patients with Morquio A syndrome in an open-label, multi-center, phase 3 extension study.
1/2018Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatment.
1/2017Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Celeste Decker Research Topics

Disease

5Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
03/2014 - 03/2008
4Hypersensitivity (Allergy)
01/2020 - 01/2017
4Mucopolysaccharidoses
01/2018 - 12/2011
3Phenylketonurias (Phenylketonuria)
01/2020 - 01/2018
2Anaphylaxis (Anaphylactic Shock)
11/2018 - 01/2017
1Food Hypersensitivity (Food Allergy)
11/2018
1Communicable Diseases (Infectious Diseases)
11/2018
1Pain (Aches)
02/2017
1Disease Progression
12/2011
1Mucopolysaccharidosis IV (Morquio Syndrome)
12/2011
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
08/2008

Drug/Important Bio-Agent (IBA)

4N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA
02/2010 - 03/2008
3pegvaliaseIBA
01/2020 - 01/2018
3Phenylalanine (L-Phenylalanine)FDA Link
01/2020 - 01/2018
3Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
01/2020 - 01/2018
3human GALNS proteinIBA
01/2018 - 01/2017
3Pharmaceutical PreparationsIBA
01/2018 - 03/2008
2EnzymesIBA
11/2018 - 01/2017
2galsulfaseFDA Link
03/2014 - 03/2008
1Immunoglobulin E (IgE)IBA
11/2018
1ametantrone (HAQ)IBA
01/2018
1Keratan SulfateIBA
02/2017
1AntibodiesIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
12/2011

Therapy/Procedure

8Enzyme Replacement Therapy
01/2018 - 03/2008
1Duration of Therapy
01/2020
1Drug Tapering
01/2020
1Activities of Daily Living (ADL)
01/2018
1Therapeutics
03/2014